FIELD: chemistry.
SUBSTANCE: invention relates to indol-3-yl-carbonyl-spiro-piperadine derivatives used as V1a receptor antagonists and which have formula I: 
, where the spiro-piperadine A head group and residues R1, R2 and R3 are as defined in claim 1 of the invention. The invention also pertains to pharmaceutical compositions which contain such compounds and use thereof in preparing medicines with V1a receptor antagonist activity.
EFFECT: high activity of derivatives.
37 cl, 1 tbl, 285 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOL-3-YL-CARBONYL-ASASPIRO DERIVATIVES AS VASOPRESSIN RECEPTOR ANTAGONISTS | 2006 |
|
RU2418801C2 |
| INDOLE-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES | 2006 |
|
RU2420529C2 |
| INDOLE-3-YL-CARBONYL-PIPERIDINE AND PIPERAZINE DERIVATIVES | 2006 |
|
RU2422442C2 |
| INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415139C2 |
| SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRA-AZA-BENZO[E]AZULENES | 2009 |
|
RU2514429C2 |
| PYRROLO- AND THIAZOLOPYRIDINE COMPOUNDS (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2461557C2 |
| SPIROINDOLINONE DERIVATIVES | 2007 |
|
RU2435771C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
| NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2617682C2 |
| BENZOYLPIPERIDINE DERIVATIVES AS 5HT AND D RECEPTOR MODULATORS | 2007 |
|
RU2396265C2 |
